These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

226 related items for PubMed ID: 14972081

  • 1. How do we choose between atypical antipsychotics? The advantages of amisulpride.
    Mortimer AM.
    Int J Neuropsychopharmacol; 2004 Mar; 7 Suppl 1():S21-5. PubMed ID: 14972081
    [Abstract] [Full Text] [Related]

  • 2. Amisulpride a selective dopamine antagonist and atypical antipsychotic: results of a meta-analysis of randomized controlled trials.
    Leucht S.
    Int J Neuropsychopharmacol; 2004 Mar; 7 Suppl 1():S15-20. PubMed ID: 14972080
    [Abstract] [Full Text] [Related]

  • 3. Amisulpride, an unusual "atypical" antipsychotic: a meta-analysis of randomized controlled trials.
    Leucht S, Pitschel-Walz G, Engel RR, Kissling W.
    Am J Psychiatry; 2002 Feb; 159(2):180-90. PubMed ID: 11823257
    [Abstract] [Full Text] [Related]

  • 4. The effects of amisulpride on five dimensions of psychopathology in patients with schizophrenia: a prospective open-label study.
    Herrera-Estrella M, Apiquian R, Fresan A, Sanchez-Torres I.
    BMC Psychiatry; 2005 May 03; 5():22. PubMed ID: 15869707
    [Abstract] [Full Text] [Related]

  • 5. Atypical antipsychotics: new directions and new challenges in the treatment of schizophrenia.
    Kapur S, Remington G.
    Annu Rev Med; 2001 May 03; 52():503-17. PubMed ID: 11160792
    [Abstract] [Full Text] [Related]

  • 6. Amisulpride versus flupentixol in schizophrenia with predominantly positive symptomatology -- a double-blind controlled study comparing a selective D2-like antagonist to a mixed D1-/D2-like antagonist. The Amisulpride Study Group.
    Wetzel H, Gründer G, Hillert A, Philipp M, Gattaz WF, Sauer H, Adler G, Schröder J, Rein W, Benkert O.
    Psychopharmacology (Berl); 1998 Jun 03; 137(3):223-32. PubMed ID: 9682999
    [Abstract] [Full Text] [Related]

  • 7. Amisulpride: a review of its use in the management of schizophrenia.
    Curran MP, Perry CM.
    Drugs; 2001 Jun 03; 61(14):2123-50. PubMed ID: 11735643
    [Abstract] [Full Text] [Related]

  • 8. Amisulpride versus olanzapine in the treatment of schizophrenia in Indian patients: randomized controlled trial.
    Bhowmick S, Hazra A, Ghosh M.
    Aust N Z J Psychiatry; 2010 Mar 03; 44(3):237-42. PubMed ID: 20050717
    [Abstract] [Full Text] [Related]

  • 9. Amisulpride: a review of its use in the management of schizophrenia.
    McKeage K, Plosker GL.
    CNS Drugs; 2004 Mar 03; 18(13):933-56. PubMed ID: 15521794
    [Abstract] [Full Text] [Related]

  • 10. Spotlight on amisulpride in schizophrenia.
    Curran MP, Perry CM.
    CNS Drugs; 2002 Mar 03; 16(3):207-11. PubMed ID: 11888341
    [Abstract] [Full Text] [Related]

  • 11. Which role for amisulpride in rehabilitation of schizophrenic patients with acute exacerbation?
    Blin O.
    Encephale; 2000 Oct 03; 26 Spec No 1():7-11. PubMed ID: 11294060
    [Abstract] [Full Text] [Related]

  • 12. Amisulpride versus risperidone in the treatment of schizophrenic patients: a double-blind pilot study in Taiwan.
    Hwang TJ, Lee SM, Sun HJ, Lin HN, Tsai SJ, Lee YC, Chen YS.
    J Formos Med Assoc; 2003 Jan 03; 102(1):30-6. PubMed ID: 12684609
    [Abstract] [Full Text] [Related]

  • 13. Acute weight gain induced by amisulpride monotherapy in a first-episode schizophrenic patient.
    Papadimitriou GN, Theleritis CG, Dikeos DG, Psarros CJ, Soldatos CR.
    Int Clin Psychopharmacol; 2006 May 03; 21(3):181-4. PubMed ID: 16528141
    [Abstract] [Full Text] [Related]

  • 14. Improvement of schizophrenic patients with primary negative symptoms treated with amisulpride. Amisulpride Study Group.
    Danion JM, Rein W, Fleurot O.
    Am J Psychiatry; 1999 Apr 03; 156(4):610-6. PubMed ID: 10200742
    [Abstract] [Full Text] [Related]

  • 15. Amisulpride improves obsessive-compulsive symptoms in schizophrenia patients taking atypical antipsychotics: an open-label switch study.
    Kim SW, Shin IS, Kim JM, Yang SJ, Hwang MY, Yoon JS.
    J Clin Psychopharmacol; 2008 Jun 03; 28(3):349-52. PubMed ID: 18480697
    [No Abstract] [Full Text] [Related]

  • 16. Is amisulpride an 'atypical' atypical antipsychotic agent?
    Lecrubier Y.
    Int Clin Psychopharmacol; 2000 Dec 03; 15 Suppl 4():S21-6. PubMed ID: 11252520
    [Abstract] [Full Text] [Related]

  • 17. Practical issues with amisulpride in the management of patients with schizophrenia.
    Pani L, Villagrán JM, Kontaxakis VP, Alptekin K.
    Clin Drug Investig; 2008 Dec 03; 28(8):465-77. PubMed ID: 18598092
    [Abstract] [Full Text] [Related]

  • 18. Combination of clozapine and amisulpride in treatment-resistant schizophrenia--case reports and review of the literature.
    Zink M, Knopf U, Henn FA, Thome J.
    Pharmacopsychiatry; 2004 Jan 03; 37(1):26-31. PubMed ID: 14750045
    [Abstract] [Full Text] [Related]

  • 19. Frontal fasciculi and psychotic symptoms in antipsychotic-naive patients with schizophrenia before and after 6 weeks of selective dopamine D2/3 receptor blockade.
    Ebdrup BH, Raghava JM, Nielsen MØ, Rostrup E, Glenthøj B.
    J Psychiatry Neurosci; 2016 Mar 03; 41(2):133-41. PubMed ID: 26599135
    [Abstract] [Full Text] [Related]

  • 20. Ziprasidone and amisulpride effectively treat negative symptoms of schizophrenia: results of a 12-week, double-blind study.
    Olié JP, Spina E, Murray S, Yang R.
    Int Clin Psychopharmacol; 2006 May 03; 21(3):143-51. PubMed ID: 16528136
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.